PROSPECTS AND OPPORTUNITIES
Analgesics faces strong growth amid demographic shifts and Vision 2030 reforms
Analgesics in Saudi Arabia is projected to enjoy significant value sales growth over the forecast period, with robust rises driven by a combination of demographic shifts, an evolving healthcare landscape and increasing health awareness, as well as a greater prevalence of chronic diseases which necessitate ongoing pain management solutions.
Digital and technological advancements set to transform analgesics
Over the forecast period, analgesics in Saudi Arabia is poised for significant digital and technological advancements, impacting product innovation, manufacturing and distribution. The Kingdom's ambitious Vision 2030, with its strong emphasis on digital transformation in healthcare, is a primary catalyst.
Regulatory development, health awareness and sustainability trends will shape future development
Over the forecast period, analgesics in Saudi Arabia will be shaped by regulatory shifts, rising health awareness and growing sustainability efforts. New SFDA health economic guidelines in 2025 require cost-effectiveness assessments for drug approvals, while a Royal Decree allowing full foreign ownership in pharmacies is set to boost competition.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Saudi Arabia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Saudi Arabia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Saudi Arabia report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Saudi Arabia?
- Which are the leading brands in Analgesics in Saudi Arabia?
- How are products distributed in Analgesics in Saudi Arabia?
- How has the regulatory and operating environment for Analgesics changed in Saudi Arabia?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Saudi Arabia - Category analysis
KEY DATA FINDINGS
Value sales rise as triptans races ahead in 2025
GSK strengthens leadership through brands boasting high recognition
Pharmacies dominates distribution as e-commerce sees further expansion
Analgesics faces strong growth amid demographic shifts and Vision 2030 reforms
Digital and technological advancements set to transform analgesics
Regulatory development, health awareness and sustainability trends will shape future development
Consumer Health in Saudi Arabia - Industry Overview
Consumer Health in 2025: The big picture
Key trends in 2025
Competitive landscape
Channel developments
What next for Consumer Health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!